Please provide your email address to receive an email when new articles are posted on . Patients with nonalcoholic fatty liver disease and liver-involved fibrosis frequently had a cholestatic pattern ...

A number of presentations held during the 54th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) addressed important advances in genetic/metabolic liver disease. A ...

To highlight the importance of actively looking for concomitant cCMV as a routine evaluation of patients presenting with cholestasis and receiving a diagnosis of an inherited liver disease, ...

Chronic cholestasis, defined as the impairment of bile acid formation and/or flow persisting for more than six months, encompasses a broad spectrum of hepatobiliary disorders, both heritable and ...

Alpha-1 antitrypsin (AAT) deficiency is an autosomal recessive genetic disease that can lead to a number of different medical conditions. Chronic liver disease, cirrhosis, and hepatocellular carcinoma ...

Please provide your email address to receive an email when new articles are posted on . For patients with severe COVID-19, cholangiopathy was a late complication with potential for progressive biliary ...

Marketing Authorization variation submitted for treatment of patients with progressive familial intrahepatic cholestasis (PFIC) two months of age and older; data supports treatment across the broadest ...

Cholestasis is a condition that can develop in your liver during the latter part of your pregnancy. You may also hear it referred to as intrahepatic cholestasis of pregnancy (ICP). It causes intense ...

Kayfanda® (odevixibat) approved as new treatment choice for cholestatic pruritus in children from six months with the rare liver condition, Alagille Syndrome E.U. marketing authorization for Kayfanda ...